These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10564321)

  • 1. Fumaric acid esters: an alternative systemic treatment for psoriasis.
    Ameen M; Russell-Jones R
    Clin Exp Dermatol; 1999 Sep; 24(5):361-4. PubMed ID: 10564321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumaric acid esters for psoriasis: a systematic review.
    Smith D
    Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
    Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
    Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
    Tzaneva S; Geroldinger A; Trattner H; Tanew A
    Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care.
    Mrowietz U; Sorbe C; Reich K; Von Kiedrowski R; Weckbecker J; Radtke MA; Rustenbach SJ; Augustin M
    Eur J Dermatol; 2020 Feb; 30(1):41-48. PubMed ID: 32250255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.
    Harries MJ; Chalmers RJ; Griffiths CE
    Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumaric acid esters in psoriasis and multiple sclerosis.
    Zecca C; Caporro M; Adami M; Mainetti C; Gobbi C
    Clin Exp Dermatol; 2014 Jun; 39(4):488-91. PubMed ID: 24779791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference.
    Mrowietz U; Christophers E; Altmeyer P
    Br J Dermatol; 1999 Sep; 141(3):424-9. PubMed ID: 10584060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.
    Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN
    Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis.
    Höxtermann S; Nüchel C; Altmeyer P
    Dermatology; 1998; 196(2):223-30. PubMed ID: 9568412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumaric acid esters in the management of psoriasis.
    Balak DM
    Psoriasis (Auckl); 2015; 5():9-23. PubMed ID: 29387578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
    Inzinger M; Weger W; Heschl B; Salmhofer W; Quehenberger F; Wolf P
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):861-6. PubMed ID: 22672248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
    Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U
    Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologists.
    Fallah Arani S; Balak DM; Neumann HA; Kuipers MV; Thio HB
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):972-5. PubMed ID: 23822581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
    Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
    Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fumaric acid esters in psoriasis.
    Roll A; Reich K; Boer A
    Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological changes in psoriasis patients under long-term treatment with fumaric acid esters: risk of Kaposi sarcoma occurrence?
    Philipp S; Kokolakis G; Hund M; Witte E; Witte K; Kunz S; Roewert HJ; Sterry W; Sabat R
    Eur J Dermatol; 2013; 23(3):339-43. PubMed ID: 23774790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
    Mrowietz U; Christophers E; Altmeyer P
    Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.
    Schmieder A; Poppe M; Hametner C; Meyer-Schraml H; Schaarschmidt ML; Findeisen P; Benoit S; Bauer B; Schmid S; Goebeler M; Goerdt S; Ludwig-Peitsch WK
    Arch Dermatol Res; 2015 Jul; 307(5):413-24. PubMed ID: 25648959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.